These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 31111351

  • 1. RAS Mutation Decreases Overall Survival After Optimal Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy of Colorectal Peritoneal Metastasis: A Modification Proposal of the Peritoneal Surface Disease Severity Score.
    Arjona-Sanchez A, Rodriguez-Ortiz L, Baratti D, Schneider MA, Gutiérrez-Calvo A, García-Fadrique A, Tuynman JB, Cascales-Campos PA, Martín VC, Morales R, Salti GI, Arteaga X, Pacheco D, Alonso-Gomez J, Yalkin O, Villarejo-Campos P, Sanchez-Hidalgo JM, Casado-Adam A, Cosano-Alvarez A, Rufian-Peña S, Briceño J.
    Ann Surg Oncol; 2019 Aug; 26(8):2595-2604. PubMed ID: 31111351
    [Abstract] [Full Text] [Related]

  • 2. P.R.O.P.S. - A novel Pre-Operative Predictive Score for unresectability in patients with colorectal peritoneal metastases being considered for cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC).
    Yong ZZ, Tan GHC, Shannon N, Chia C, Teo MCC.
    World J Surg Oncol; 2019 Aug 07; 17(1):138. PubMed ID: 31391066
    [Abstract] [Full Text] [Related]

  • 3. The American Society of Peritoneal Surface Malignancies (ASPSM) Multiinstitution Evaluation of the Peritoneal Surface Disease Severity Score (PSDSS) in 1,013 Patients with Colorectal Cancer with Peritoneal Carcinomatosis.
    Esquivel J, Lowy AM, Markman M, Chua T, Pelz J, Baratti D, Baumgartner JM, Berri R, Bretcha-Boix P, Deraco M, Flores-Ayala G, Glehen O, Gomez-Portilla A, González-Moreno S, Goodman M, Halkia E, Kusamura S, Moller M, Passot G, Pocard M, Salti G, Sardi A, Senthil M, Spilioitis J, Torres-Melero J, Turaga K, Trout R.
    Ann Surg Oncol; 2014 Dec 07; 21(13):4195-201. PubMed ID: 24854493
    [Abstract] [Full Text] [Related]

  • 4. Colorectal Peritoneal Metastases Treated by Perioperative Systemic Chemotherapy and Cytoreductive Surgery With or Without Mitomycin C-Based HIPEC: A Comparative Study Using the Peritoneal Surface Disease Severity Score (PSDSS).
    Baratti D, Kusamura S, Azmi N, Guaglio M, Montenovo M, Deraco M.
    Ann Surg Oncol; 2020 Jan 07; 27(1):98-106. PubMed ID: 31691116
    [Abstract] [Full Text] [Related]

  • 5. High-grade postoperative complications affect survival outcomes of patients with colorectal Cancer peritoneal metastases treated with Cytoreductive surgery and Hyperthermic Intraperitoneal chemotherapy.
    Zhou S, Feng Q, Zhang J, Zhou H, Jiang Z, Liu Z, Zheng Z, Chen H, Wang Z, Liang J, Pei W, Liu Q, Zhou Z, Wang X.
    BMC Cancer; 2021 Jan 07; 21(1):41. PubMed ID: 33413223
    [Abstract] [Full Text] [Related]

  • 6. Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP).
    Cascales-Campos PA, López-López V, Torres-Melero J, Arjona A, Muñoz-Casares FC, Barrios P, Morales R, Pereira F, Bretcha-Boix P, González-Bayón L, González-Moreno S, Gil J.
    Clin Transl Oncol; 2020 Jan 07; 22(1):130-136. PubMed ID: 31049819
    [Abstract] [Full Text] [Related]

  • 7. Treatment of Isolated Peritoneal Recurrences in Patients with Colorectal Peritoneal Metastases Previously Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    van Eden WJ, Elekonawo FMK, Starremans BJ, Kok NFM, Bremers AJA, de Wilt JHW, Aalbers AGJ.
    Ann Surg Oncol; 2018 Jul 07; 25(7):1992-2001. PubMed ID: 29671139
    [Abstract] [Full Text] [Related]

  • 8. Peritoneal carcinomatosis index predicts survival in colorectal patients undergoing HIPEC using oxaliplatin: a retrospective single-arm cohort study.
    Burnett A, Lecompte MA, Trabulsi N, Dubé P, Gervais MK, Trilling B, Cloutier AS, Sideris L.
    World J Surg Oncol; 2019 May 15; 17(1):83. PubMed ID: 31092250
    [Abstract] [Full Text] [Related]

  • 9. Repeat Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemoperfusion is Feasible and Offers Survival Benefit in Select Patients with Peritoneal Metastases.
    Choudry HA, Bednar F, Shuai Y, Jones HL, Pai RK, Pingpank JF, Ahrendt SS, Holtzman MP, Zeh HJ, Bartlett DL.
    Ann Surg Oncol; 2019 May 15; 26(5):1445-1453. PubMed ID: 30825033
    [Abstract] [Full Text] [Related]

  • 10. More Synchronous Peritoneal Disease but Longer Survival in Younger Patients with Carcinomatosis from Colorectal Cancer Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy.
    Solomon D, DeNicola NL, Feferman Y, Bekhor E, Reppucci ML, Feingold D, Aycart SN, Magge DR, Golas BJ, Labow DM, Sarpel U.
    Ann Surg Oncol; 2019 Mar 15; 26(3):845-851. PubMed ID: 30643994
    [Abstract] [Full Text] [Related]

  • 11. Is advanced age a hesitation for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in colorectal cancer?
    Cigdem Arslan N, Bisgin T, Altay C, Yavuzsen T, Karaoglu A, Canda AE, Sarioglu S, Sokmen S.
    J BUON; 2018 Dec 15; 23(7):77-83. PubMed ID: 30722115
    [Abstract] [Full Text] [Related]

  • 12. Iterative cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy for colorectal peritoneal metastases: A multi-institutional experience.
    Alzahrani NA, Valle SJ, Fisher OM, Sugarbaker PH, Yonemura Y, Glehen O, Goere D, Honore C, Brigand C, de Hingh I, Verwaal VJ, Deraco M, Baratti D, Kusamura S, Pocard M, Piso P, Maerz L, Marchal F, Moran B, Levine EA, Dumont F, Pezet D, Abboud K, Kozman MA, Liauw W, Morris DL, Peritoneal Surface Oncology Group International (PSOGI) and Big-RENAPE groups.
    J Surg Oncol; 2019 Mar 15; 119(3):336-346. PubMed ID: 30554404
    [Abstract] [Full Text] [Related]

  • 13. The American Society of Peritoneal Surface Malignancies Multi-Institution evaluation of 1,051 advanced ovarian cancer patients undergoing cytoreductive surgery and HIPEC: An introduction of the peritoneal surface disease severity score.
    Foster JM, Sleightholm R, Smith L, Ceelen W, Deraco M, Yildirim Y, Levine E, Muñoz-Casares C, Glehen O, Patel A, Esquivel J.
    J Surg Oncol; 2016 Dec 15; 114(7):779-784. PubMed ID: 27792292
    [Abstract] [Full Text] [Related]

  • 14. Impact of Synchronous Versus Metachronous Onset of Colorectal Peritoneal Metastases on Survival Outcomes After Cytoreductive Surgery (CRS) with Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Multicenter, Retrospective, Observational Study.
    Hentzen JEKR, Rovers KP, Kuipers H, van der Plas WY, Been LB, Hoogwater FJH, van Ginkel RJ, Hemmer PHJ, van Dam GM, de Hingh IHJT, Kruijff S.
    Ann Surg Oncol; 2019 Jul 15; 26(7):2210-2221. PubMed ID: 30877495
    [Abstract] [Full Text] [Related]

  • 15. Peritoneal Carcinomatosis of Urachus Origin Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC): An International Registry of 36 Patients.
    Mercier F, Passot G, Villeneuve L, Levine EA, Yonemura Y, Goéré D, Sugarbaker PH, Marolho C, Bartlett DL, Glehen O, BIG-RENAPE Working Group.
    Ann Surg Oncol; 2018 Apr 15; 25(4):1094-1100. PubMed ID: 29238881
    [Abstract] [Full Text] [Related]

  • 16. RAS Mutation Status Confers Prognostic Relevance in Patients Treated With Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Colorectal Cancer.
    Morgan Z, Chow BE, Strong EA, Tsai S, Christians K, Mogal H, Gamblin TC, Clarke CN.
    J Surg Res; 2019 Aug 15; 240():130-135. PubMed ID: 30928770
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Mutations of RAS/RAF Proto-oncogenes Impair Survival After Cytoreductive Surgery and HIPEC for Peritoneal Metastasis of Colorectal Origin.
    Schneider MA, Eden J, Pache B, Laminger F, Lopez-Lopez V, Steffen T, Hübner M, Kober F, Roka S, Campos PC, Roth L, Gupta A, Siebenhüner A, Kepenekian V, Passot G, Gertsch P, Glehen O, Lehmann K.
    Ann Surg; 2018 Nov 15; 268(5):845-853. PubMed ID: 30303876
    [Abstract] [Full Text] [Related]

  • 19. Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for Gastric Cancer with Peritoneal Carcinomatosis: Multicenter Study of Spanish Group of Peritoneal Oncologic Surgery (GECOP).
    Manzanedo I, Pereira F, Rihuete Caro C, Pérez-Viejo E, Serrano Á, Gutiérrez Calvo A, Regueira FM, Casado-Adam Á, Cascales-Campos PA, Arteaga X, García-Fadrique A, Gómez Sanz R, López García A, Zozaya G, Arjona Á, Gil Martínez J.
    Ann Surg Oncol; 2019 Aug 15; 26(8):2615-2621. PubMed ID: 31115852
    [Abstract] [Full Text] [Related]

  • 20. Extreme cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: Outcomes from a single tertiary center.
    Berger Y, Aycart S, Mandeli JP, Heskel M, Sarpel U, Labow DM.
    Surg Oncol; 2015 Sep 15; 24(3):264-9. PubMed ID: 26143715
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.